Your session is about to expire
← Back to Search
Behavioural Intervention
Green Environment for Community Health Improvement (HEAL Trial)
N/A
Recruiting
Led By Rachel Keith, PhD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
30-70 years of age
Be older than 18 years old
Must not have
HIV/AIDS, active treatment for cancer, active bleeding including wounds
Body weight less than 100 pounds or BMI>40
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 2 year followup
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how the environment and neighborhood characteristics affects the health of the area residents.
Who is the study for?
This trial is for individuals aged 30-70 living in a specific study area, who are not prisoners or part of other vulnerable groups. Participants must be able to consent and should not have HIV/AIDS, active cancer treatment, active bleeding issues, weigh less than 100 pounds or have a BMI over 40.
What is being tested?
The study investigates the impact of neighborhood green spaces on heart health and well-being. It aims to understand how environmental changes like increased greenery can influence cardiovascular disease risk and metabolic health.
What are the potential side effects?
Since this intervention involves environmental changes rather than medical treatments, traditional side effects are not expected. However, there may be indirect effects on lifestyle or well-being due to alterations in neighborhood characteristics.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 30 and 70 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have HIV/AIDS, am not currently being treated for cancer, and do not have any active bleeding or wounds.
Select...
I weigh less than 100 pounds or my BMI is over 40.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 2 year followup
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 2 year followup
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Cardiovascular Measurements. Change from Baseline Systolic and Diastolic pressures at baseline and 2 year followup.
Secondary study objectives
Body fat
Body lean mass
Bucchal swab
+25 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Targeted neighborhoods for GreennessExperimental Treatment1 Intervention
Using greenness as a therapeutic intervention, we will plant shrubs, grasses, young and mature trees (40-50 ft in height), so that we can evaluate changes in health and pollution, 2 years after planting.
Group II: Control GroupActive Control1 Intervention
No intervention
Find a Location
Who is running the clinical trial?
The Nature ConservancyUNKNOWN
University of LouisvilleLead Sponsor
348 Previous Clinical Trials
76,543 Total Patients Enrolled
National Institute of Environmental Health Sciences (NIEHS)NIH
291 Previous Clinical Trials
1,233,613 Total Patients Enrolled
Rachel Keith, PhDPrincipal Investigator - University of Louisville
University Of Louisville School Of Medicine (Medical School)
Aruni Bhatnagar, PhDStudy DirectorUniversity of Louisville
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 30 and 70 years old.I do not have HIV/AIDS, am not currently being treated for cancer, and do not have any active bleeding or wounds.I weigh less than 100 pounds or my BMI is over 40.I am between 30 and 70 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Control Group
- Group 2: Targeted neighborhoods for Greenness
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.